- The evolving landscape of PARP inhibitors in castration-resistant prostate cancer: a spotlight on treatment combinations.
- Teply BA, Antonarakis ES.
- Expert Rev Clin Pharmacol. 2022 Oct 26. doi: 10.1080/17512433.2022.2140656. Epub ahead of print.
- PMID: 36285641
- PubMed abstract
- Source abstract
- Review